GENE ONLINE|News &
Opinion
Blog

Stock Market
Special BIO2022
BIO 2022: Options for Raising Capital in a Down Market
2022-08-01
IPO Asia
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
IPO
Is the Path to Public Market Smooth? A Candid Discussion on SPACs
2021-06-15
Trials & Approvals
Citius Pharma Makes Calculated Market Moves with Phase 3 Results Looming for Potential Blockbuster Product
2021-02-21
IPO
Vor BioPharma Surpasses $1 Billion Valuation After IPO
2021-02-07
Ranking & Reports
2020-China’s Biomedicine Industry Ushers New Upsurge of IPO listings
2020-12-07
IPO Codiak Biosciences
Cambridge Startup’s Take Two at Public Debut is Off to a Slow Start
2020-10-18
Trials & Approvals
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top